This section explains how to tell the difference, what doctors usually recommend, and what to consider before deciding whether to continue treatment
The approval would open "up the opportunity for many more people to benefit from tirzepatide," Eli Lilly CEO David Ricks said Thursday on CNBC's "Squawk Box." He added that the drug sets a "new bar for weight loss and people with diabetes." The data come as companies try to capitalize on increased consumer demand for weight loss treatments
Drafting the work or revising: A.B.M.K.H., M.S.A., D.D., T.S., F.T.Z.A., L.N
However, tirzepatide delays gastric emptying, which can affect how quickly oral medications are absorbed
If bloating is severe, painful, or does not improve, it may signal a more serious problem